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ABSTRACT
Background: Pain is a common problem after stroke and is associated with poor outcomes.
There is no consensus on the optimal method of pain assessment in stroke. A review of the
properties of tools should allow an evidence based approach to assessment.
Objectives: We aimed to systematically review published data on pain assessment tools used
in stroke, with particular focus on classical test properties of: validity, reliability, feasibility,
responsiveness.
Methods: We searched multiple, cross-disciplinary databases for studies evaluating properties
of  pain  assessment  tools  used  in  stroke.   We  assessed  risk  of  bias  using  the  Quality
Assessment  of  Diagnostic  Accuracy  Studies  tool.   We  used  a  modified  harvest  plot  to
visually represent psychometric properties across tests.
Results:   The  search  yielded  12  relevant  articles,  describing  10  different  tools  (n=1106
participants).  There was substantial heterogeneity and an overall high risk of bias.  The most
commonly assessed property was validity (eight studies) and responsiveness the least (one
study).  There were no studies with a neuropathic or headache focus. Included tools were
either scales or questionnaires. The most commonly assessed tool was the Faces Pain Scale
(FPS) (6 studies). The limited number of papers precluded meaningful meta-analysis at level
of pain assessment tool or pain syndrome.  Even where common data were available across
papers, results were conflicting e.g. two papers described FPS as feasible and two described
the scale as having feasibility issues.
Conclusion: Robust data on the properties of pain assessment tools for stroke are limited. Our
review highlights specific areas where evidence is lacking and could guide further research to
identify the best tool(s) for assessing post-stroke pain. Improving feasibility of assessment in
stroke survivors should be a future research target.
Systematic review registration number:PROSPERO CRD42019160679 
Available from:https://www.crd.york.ac.uk/prospero/display_record.php?
ID=CRD42019160679
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INTRODUCTION
Pain is a common problem after stroke [1].  Estimates of the frequency of pain vary across
papers, depending on the population assessed and whether the focus is incident or prevalent
pain.  Large cohorts of mild to moderate stroke survivor suggest pain incidence of around
10% [2], while in smaller cohorts figures range from 30% during the first months [3], to 48%
at one year [4] and 43% at ten years [5] after stroke.
Post-stroke  pain  is  associated  with  disability  and  reduced  quality  of  life  [1].  It  is
independently associated with fatigue [6], depression [7] and has been strongly linked with
suicidality  [8,9].  Pain  after  stroke  can  have  a  variety  of  aetiologies  and  manifestations,
including: shoulder pain, headache, neuropathic pain and exacerbation of pre-existing pain.
Pain symptoms can present at any point during stroke recovery and may progress to chronic
pain if not recognised and treated appropriately.  
The  first  step  in  managing  post-stroke  pain  is  recognition  and  measurement.   However,
management of pain has not always been given the same priority as other aspects of stroke
care such as instituting secondary prevention [10].  Pain assessment is a complicated task
made more challenging in the context of stroke.  Since pain is a subjective experience, self-
report scales and questionnaires are the most commonly employed pain assessment tools in
clinical  practice  and  pain  may  be  part  of  a  more  general  health  related  quality  of  life
assessment [11]. However, stroke impairments such as cognitive decline and communication
issues may make it difficult for stroke survivors to communicate the presence and experience
of pain using these tools [12,13]. Other impairments such as visual issues or loss of motor
skills may further complicate the use of self-completion questionnaires or visual analogue
scales.  
Accepting these caveats, there is a range of pain assessment tools available that could be used
with stroke survivors. Some are generic, some are specific to a certain pain syndrome and
some are  developed exclusively  for  stroke.  At  present  there  is  no consensus  on the  best
approach to assessing post-stroke pain and no standardised tool is recommended for research
or practice [14]. In the absence of a gold standard pain assessment in stroke survivors and
with the great variety of assessment tools available, clinicians may struggle to know the most
appropriate approach for their patients. The choice of assessment tools should be guided by
evidence,  particularly,  the psychometric  properties  of the pain assessment  tools available.
3
Classical test features such as validity and responsiveness have been described for certain
pain tools,  however,  equally important  are end-user evaluations  such as acceptability  and
feasibility within the person’s healthcare setting.  
A summary of psychometric properties of pain assessment tools could help clinicians and
researchers choose the most appropriate measure, highlighting strengths and limitations and
also showing where new evidence is needed. Thus, we conducted a systematic review to
compare methods of pain assessment following stroke with a particular focus on properties of
validity, reliability, feasibility and responsiveness.
METHODS
We  performed  a  systematic  review,  following  best  practice  [15]  and  where  appropriate
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting
guidance [16]. Two assessors (SE, TQ) performed all aspects of title selection, data extraction
and analyses with disagreements resolved through discussion.  
As  our  focus  was  test  properties,  we  structured  our  review  question  using  the  format
recommended for test accuracy evidence synthesis [17].  
 Index test: Any measure of pain that gives an objective read out.
 Reference standard: Any measure that provides data on the classical test properties of
interest namely validity, reliability, feasibility and responsiveness.
 Condition: Stroke of any kind and at any stage in stroke journey. 
 Setting: Any healthcare setting. 
Search  strategy:  We  searched  the  following  databases,  chosen  to  represent  the  various
disciplines  that  may  assess  post-stroke  pain:  Medline  (Ovid),  Embase  (Ovid),  CINAHL
(EBSCO)  and  PsychInfo  (EBSCO).  All  were  searched  from inception  to  1st May  2020.
Search concepts were ‘stroke’ and ‘pain’ and ‘assessment’. We used validated search filters
for  ‘stroke’  and  ‘pain’,  taken  from the  relevant  Cochrane  review  group  (Supplementary
materials). We complemented our search by contacting members of an international stroke
pain research group to ensure we had not missed relevant studies.
We screened titles, abstracts and then full text to inform decisions on inclusion. Forward and
backward  citation  searching  was  conducted  for  relevant  studies  using  Web  of  Science
functionality. As a test of search validity we pre-specified two papers (one original research
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and one review) that should be returned on our literature search [1, 18]. As a further test we
cross-checked our included papers with a systematic review of pain assessment in aphasia,
recognising that the topics were distinct but were likely to have considerable overlap [14].
Selection criteria:  The population  of  interest  was adult  stroke  survivors  at  any stage  of
recovery. We did not include traumatic brain injury.  If a mixed population was included,
stroke had to represent more than 75% of the group. The test of interest was any form of pain
assessment, including scales, questionnaires, observations and other patient reported outcome
measures. Outcomes of interest were psychometric properties of the tools as defined below.
We included studies of any quantitative design, conducted in any healthcare setting, noting
setting as part of our data extraction. We only included studies published in peer reviewed
journals but applied no other restrictions.
Data collection process and data items: We designed and piloted a bespoke data collection
form using the paper that original research paper that informed our internal validation [18].  
We collected data on the following: 
Study  details:  publication  date,  country,  study  design  (i.e. cross-sectional,  prospective,
retrospective),  psychometric  properties  assessed  (validity,  feasibility,  intra/inter-reliability,
responsivity), sample size.
Stroke  details:  stroke  classification  (for  example ischaemic  or  haemorrhagic),  time  since
stroke, setting (classified as: acute stroke unit, rehabilitation, outpatient, community, using
descriptions  in the original  paper),  inclusion/exclusion criteria  in original  study, noting if
there were specific exclusions relating to language or coignition.
Pain assessment:  type of pain (see below), method(s) of pain assessment (i.e. pain scales,
questionnaires,  stroke  specific  or  generic),  pain  assessor(s)  (i.e. researcher  or  clinical
discipline).   For articles comparing multiple  methods of pain assessment,  we included all
tools and recorded the primary pain assessment tool. 
Categorization of pain syndromes: We categorised pain using the following pre-specified
labels: neuropathic, nociceptive (noting the site  i.e. lower limb), headache or experimental
(i.e. investigator induced pain). We classified stroke shoulder pain as a distinct category as it
can include both nociceptive and neuropathic elements. Our pain classification was based on
the description in the original paper. Where the nature of the pain syndrome was not clear,
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two reviewers (SE, TQ) discussed and came to consensus. For some papers, lack of detail
precluded applying any label with certainty, and these were categorised as ‘non-specified’.
Psychometric properties: We were interested in the following psychometric properties: 
validity, reliability, feasibility, responsiveness. These were defined as [19, 20]:
 Validity: the extent to which an instrument measures what is intended, in this case, is
the tool a measure of pain? The concept of ‘accuracy’ would be included as a measure
of validity.
 Reliability: the internal consistency of an instrument, and the degree to which it is free
from error on repeated. We included measures of inter-observer, intra-observer and
internal reliability.
 Feasibility:  usability,  and  acceptability  of  an  instrument  from  the  perspective  of
assessors and those being assessed.
 Responsiveness:  the  ability  of  the  instrument  to  distinguish  clinically  important
changes over time.
On initial scoping it became clear that a traditional quantitative meta-analysis would not be
possible, due to the substantial clinical heterogeneity across studies in terms of populations
assessed, methods used, nature of pain assessments and psychometric properties described.
To allow cross-study comparisons, we created summary measures of the study findings at the
level of the psychometric property studied. Our categorisation was based on the conclusions
of the original paper and was agreed by consensus. We classified results as positive, neutral
or inconclusive.
Risk of bias: We assessed risk of bias for included studies at the outcome level. Two (SE,
TQ) investigators individually assessed papers and agreed final grading. No single quality
assessment tool would be suitable for the variety of methodologies that were included in our
eligible papers. We elected to use the Quality Assessment of Diagnostic Accuracy Studies 2
(QUADAS-2) tool [21]. QUADAS-2 is designed for assessing studies of test accuracy and
uses a framework suited to our review with assessment of bias and applicability across four
domains:  patient  selection,  index  tests,  reference  standard,  flow  and  timing  [17].  As
recommended, we took the original QUADAS-2 anchoring statements and modified to suit
our  review  (modified  domain  questions  included  in  supplementary  materials).  We  used
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robvis R package software to create summary ‘traffic light’ plots [22]. Due to the limited
number of studies and heterogeneity in summary measures we did not perform quantitative
assessment for publication bias.
Evidence Synthesis: We created two summary tables (Table 1, Table 2): the first describes
key characteristics of the included articles and the second summarises their results. Our data
were heterogeneous and required representation of differing constructs across various axes.
To  allow a  visual  representation  that  included  pain  syndrome,  pain  assessment  tool  and
results  of psychometric  testing across various constructs we created a visual  plot using a
modified harvest plot [23]. We created a matrix that plotted results by pain assessment tool
(we created space in the plot for subcategorising by pain scales and questionnaires) against
each psychometric property of interest. We colour-coded according to pain type with one unit
of plot  space per  study/experiment  and then assigned the results  of the study as positive
(above a horizontal line of no effect), neutral (below the line) or inconclusive (crossing the
line).   
RESULTS
The initial search yielded 2851 articles, with 12 [9,18,24-33] papers (n=1106 participants)
meeting the inclusion criteria (Figure 1). Our search results suggested a valid search as they
included  the  two  pre-selected  papers  and  had  all  the  relevant  studies  from the  previous
aphasia review. The number of participants  ranged from 19 to 388. The most commonly
employed design was cross-sectional (n=6) with the majority of studies (n=6) conducted in a
rehabilitation setting (Table 1, Supplementary Materials).
In total, 10 different pain scales and questionnaires were assessed across the 12 studies (Table
1). These were: Visual Analogue Scale (VAS [differing scales described as VAS]), the Faces
Pain Scale (including a revised version), Numerical Rating Scale, and various combinations
of these; the Pain Assessment Scale for Seniors with Severe Dementia-II (PACSLAC-II), and
three  questionnaires:  AbilityQ,  ShoulderQ  and  the  neuropathic  pain  diagnostic
questionnaire (DN4).  Of  the  included  assessments,  only  the  ShoulderQ  was  developed
specifically  for  stroke.   The  Faces  Pain  Scale  was  the  most  commonly  reported,  with  a
version used in six of the 12 studies.
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Where  a  pain  category  was  described,  the  most  commonly  studied  was  shoulder  pain.
Neuropathic  pain  and  Headache  were  not  studied,  except  in  those  papers  that  did  not
differentiate pain type.  There was heterogeneity in the tools assessed for each pain category,
with no pain category having more than two studies using a common tool (Table 3).
There was a high risk of bias detected in the majority of included papers (n=8; Figure 2).
Highest  risk of  bias  and issues  with  generalisability  was seen  for  the  domain  of  patient
selection (n=10; judged high risk).  This was due to  exclusion of patients  for whom pain
assessment would be expected in clinical practice, including those with pre-stroke pain (n=5
papers), aphasia (n=3) and cognitive impairment (n=3). There was poor reporting of study
methods relevant to the risk of bias assessment, particularly around blinding of results when a
study compared scales. Only four papers were judged to have overall low risk of bias [18,31-
33] 
We created a visual synthesis of the psychometric properties of the tools used to assess pain
as a modified harvest plot (Figure 3).  The harvest plot approach allows visual display of data
across several axes in one figure.  We represented each study as a single unit (square), and
colour coded based on pain type.  Columns delineated differing assessment tools and rows
the properties of interest.  A horizontal line that bisected each row was a line of uncertain
effect, if a study claimed that the psychometric property of interest was ‘good’ i.e. acceptable
for clinical use then the study was placed above the line, if the paper reported that the study
was ‘poor’ i.e. would not be suitable it was placed below the line. 
All  psychometric  domains of interest  were reviewed by at  least  one article,  although the
statistical  approach  to  these  assessments  varied.  Validity  was  the  psychometric  property
evaluated most frequently (n=8),  and responsiveness was only considered by one article. In
general pain scales assessed were judged to be valid measures by the authors of the studies,
with only two studies reporting concerns around validity (Figure 3). A version of the Faces
Pain  Scale was  the  most  commonly  assessed  pain,  with  evaluations  of  validity  (n=3),
reliability  (n=3)  and  feasibility  (n=2).  However,  results  were  conflicting,  for  example
feasibility of FPS was assessed as good, neutral and poor across the studies (Figure 3). 
DISCUSSION
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We aimed to systematically review the psychometrics of pain assessment tools when used
with stroke survivors. We found a limited literature with substantial heterogeneity in the tools
used, the research methods employed and the properties assessed. The available data were
limited  by risk of  bias  and modest  sample  sizes.   Thus,  we are unable  to  recommend  a
preferred tool based on published psychometric properties. However, through our evidence
synthesis,  we have  highlighted  important  evidence  gaps  that  can  inform the  direction  of
future research activity in the pain assessment space. 
Our mapping of the evidence using the harvest plot demonstrates the many limitations in the
evidence  base.  Of  the  four  key  psychometric  properties,  there  was  little  information  on
reliability, and responsiveness. Even where there was a portfolio of papers on a single tool it
was  difficult  to  draw  conclusions.  There  were  more  studies  on  visual  scales  than
questionnaires, with few studies using a scale specifically developed for stroke and no studies
with a neuropathic or headache pain focus.
Our findings of inconsistent and inconclusive evidence are not unique to stroke. A previous
review of  pain  assessment  in  aphasia  concluded  that  ‘a  feasible,  reliable  and  valid  pain
assessment instrument is not yet available’ [14]. Dementia is another clinical condition where
pain is common but potentially difficult to assess. Although there is more published literature
on dementia pain assessment tools [34], conclusions of reviews are similar ‘limited evidence
about reliability, validity and clinical utility’ [35].  This seems a missed opportunity, as well
as the clinical importance, pain assessment could be a useful research outcome [36]. 
Our  assessment  of  risk  of  bias  suggests  common  areas  of  concern  particularly  around
reporting  and  generalisability.  Exclusion  of  stroke  survivors  with  aphasia,  dementia  or
comorbidity threatens the external validity of study results.  Similar exclusions have been
demonstrated in other aspects of stroke assessment [37].  Certain scales may not be suitable
for all stroke impairments, but simply excluding those people who may struggle to complete
an assessment creates bias in any resulting estimates.[38]  
Our  review has  several  strengths.  We performed  a  comprehensive  search,  followed  best
practice  guidance  and  embedded  internal  validation  steps.  Given  the  disparate  nature  of
relevant studies, we used non-traditional methods for evidence synthesis and assessment of
quality. There are limitations to our approach. Despite internal and external validity steps we
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may have missed relevant papers. We were not able to perform quantitative meta-analysis
either at an aggregate level or at the level of differing pain types, but instead used a relatively
novel method of visual data synthesis. Our modified harvest plot approach gives a summary
of the totality of the data across various axes, allowing for visual comparisons across tools.
This approach could be applied in other complex reviews with substantial heterogeneity in
the supporting literature. 
Despite the prevalence of post-stroke pain, studies describing the best way to assess for this
problem are limited in number and quality. Our evidence mapping and quality assessments
highlight particular pain syndromes and tests that have no empirical evidence base.  No pain
assessment had sufficient data to be considered definitive and further, robust research for any
pain tool would be a welcome addition. 
In light of this uncertainty what conclusions can be made?  Patient based scales, such as faces
pain scale, seem to have the most supporting evidence and are a valid means to assess pain.
Our review suggests there are many evidence gaps requiring future research, but methods to
improve feasibility of assessment seem an important target.  
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Table 1:Key Characteristics of included papers
Table 1:Characteristics of included papers (shortened version)
Author/s Study 
Design
Psychometric 
properties 
assessed
Number
included
Age (years)
(mean, SD) 
Stroke setting Exclusion Criteria Type of pain Pain 
Assessment
tool
Pain Assessor
1. Benaim 
[9]
Cross-
sectional
Validity,  
Reliability
127 63 ± 8 Rehabilitation cognitive impairments, 
psychiatric disorders
Shoulder Pain FPS Unknown
2. Chuang 
[31]
Prospective Reliability 50 52.6 ± 11.0
 
Outpatient other acute pain 
conditions, major 
medical problems, 
psychological 
impairments, aphasia
Arm/Shoulder
pain
v-NPRS-
FPS 
Clinical staff 
(Rehabilitation 
physicians)
3. Dogan 
[26]
Case control Validity 60 
including
non-
stroke 
control 
(n=30)
64.2 ± 9.42 Rehabilitation Pre-existing pain 
conditions, cognitive 
impairment, aphasia
Shoulder Pain FPS Unknown
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4. Korner-
Bitensky 
[27]
Cross-
sectional
Validity 90 Not available Rehabilitation cognitive impairments, 
central post-stroke pain 
syndrome
Experimental 
(thermal)
10-cm v-
VAS 
Clinical staff 
(SLT), 
Researcher
5. Price 
[18] 
Case control Feasibility, 
Validity
144 
including
non-
stroke 
controls 
(n=48)
72.5 mean Acute stroke unit reduced conscious level
or dysphasic
Experimental 
(pressure)
v/m/h-VAS Researcher
6. Smith 
[25] 
Retrospective Feasibility 388 77 (IQR:66–86) Acute stroke unit subsequent strokes Not specified FPS and/or 
NRS
Clinical staff 
(Nurses)
7. Roosink 
[24] 
Cross-
sectional
Validity 19 57.5 ±7. 5 Rehabilitation other chronic pain 
conditions, neurological
deficits
Shoulder Pain DN4 Unknown
8. Turner-
Stokes 
(2003) [28]
Cross-
sectional
Validity, 
Reliability, 
Feasibility
49 52.6 ± 3.1 Rehabilitation not specified Shoulder Pain AbilityQ, 
ShoulderQ
Researcher
9. Turner-
Stokes 
(2006) [29]
Retrospective Responsiveness 30 47.2 ± 2.2 Rehabilitation not specified Shoulder Pain AbilityQ, 
ShoulderQ
Clinical staff 
(Nurses)
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10. 
Mandysov
a [30] 
Cross-
sectional
Validity, 
Reliability, 
Feasibility
80 71.0 ± 13.7 (range 
22–94) 
Acute stroke unit reduced conscious level Not specified VAS/NRS, 
NRS, 
FPS-R 
Researcher 
11. 
Pomeroy 
[32] 
Prospective Reliability 33 74 (range 57–89) Community reduced conscious 
level, other pain 
conditions, no irregular 
pain medication, no 
neurological/MSK 
disorders
Shoulder Pain 10-cm v-
VAS 
Clinical staff 
(Physiotherapist)
12. Soares 
[33] 
Cross-
sectional 
Reliability, 
Validity
36 61 median (range 46 
- 71.75) 
Acute stroke unit neurological disorders Experimental 
(mechanical)
PACSLAC-
II 
Clinical staff 
(Neurology 
nurses)
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Study design and setting were categorised and agreed by two raters (SE, TQ)
FPS = Faces Pain Scale; NRS/NPRS = Numerical Rating Scale; VAS = Visual Analogue Scale, v-/m-/h- = vertical/mechanical/horizontal
NPRS-FPS and VAS/NRS indicate combined versions of scales
DN4 = neuropathic pain diagnostic questionnaire; PACSLAC-II = Pain Assessment Scale for Seniors with Severe Dementia-II
SLT = Speech and Language Therapy
N.B. more comprehensive version of table is available in Supplementary Materials
Table 2:Summary of results from included articles
Author/s Pain 
assessment 
(comparat
or)
Results
1. 
Benaim 
[9]
FPS 
(VAS, 
VRS)
 Validity  : Correlation of FPS with VAS and VRS in both left and right hemisphere stroke (r=0.65–0.82)
 Reliability  :
 Inter-rater:  K:0.64 (SE=0.11) and K:0.44 (0.09) in left and right hemisphere stroke respectively. 
 Intra-rater:  K:0.74 (0.13) and K:0.53 (0.10) in left and right hemisphere stroke respectively. 
 Feasibility  : FPS was preferred in left hemisphere stroke, VAS was preferred in right hemisphere stroke. 
2. 
Chuang 
[31]
v-NPRS-
FPS 
 Reliability (intra-rater):  ICC=0.82 (SE=0.81), [smallest real difference=1.87]. 
 No significant systematic bias between repeated measurements for NPRS-FPS.
 High level of stability and minimal temporal variation, range of limits of agreement (-2.50 to 1.90) 
3. Dogan 
[26]
FPS
(VAS, LPS,
NRS)
 Validity  : Correlation of FPS with other pain scales in both groups (r=0.95–0.97 and 0.67–0.93, respectively). 
4. 
Korner-
Bitensky 
[27]
10-cm v-
VAS 
 Validity  : No between group difference in pain discrimination (p=0.75). 
 Repeated-measures ANOVA revealed no effect of group. 
5. Price 
[18] 
v/m/h-VAS
FPRS, NRS
 Feasibility  : Inability to complete scales was associated with stroke (P 0.01).
 Association between completion and milder stroke (P<0.01).
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 Associations (P<0.05) between impairments tested and inability to complete scales.
6. Smith 
[25] 
FPS, NRS  Feasibility  : 13.4% individuals unable to provide a meaningful response to either FPS or NRS.
 Associations between inability to self-report pain and: stroke severity (P<0.001), 
                                                                                                  aphasia severity (P<0.001)
                                                                                                  consciousness (P<0.001).
 Validity:   Associations between inability to self-report pain and mortality (P<0.001). 
7. 
Roosink 
[24] 
DN4
(NRS)
 Validity  : DN4+ classified patients reported:  constant pain [DN4+:n=4 (44%); DN4-:n=0 ]
                                                                               higher pain intensity [DN4+=4.7 (SD=2.9); DN4- =2.5 
(SD=2.4)]
                                                                               higher impact of pain on daily living DN4+=5.9 (SD= 4.8), 
DN4- =2.0 (SD=2.6)
                                                                               more frequent loss of cold sensation [DN4+:n=7 (78%); 
DN4-:n=2 (20%)] 
 Signs and symptoms suggestive of neuropathic or nociceptive pain corresponded to DN4+ and DN4- 
respectively.
8. Turner-
Stokes 
(2003) 
[28]
AbilityQ, 
ShoulderQ
(VAS)
 Validity:  VAS agreement ±1 on a 10-point scale was 36–59% with intraclass correlation coefficients 0.50–0.60 
(p<0.01).
 Reliability:  Agreement for individual questions 55- 88%; K:0.07-0.79
 Repeatability of ShoulderQ 36–72%, K:0.16–0.56.
 Feasibility:  N=31 (63%) required help in completing AbilityQ. 
9. Turner- AbilityQ,  Responsiveness  : Changes on VGRS associated with verbal reports of improvement (r:0.67, P<0.001).
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Stokes 
(2006) 
[29]
ShoulderQ
(VGRS)
 Responders demonstrated significant change in VGRS and verbal scores, whereas non-responder group did not.
– A change in summed VGRS score of ≥3 showed 77% sensitivity and 91.3% specificity for identifying 
responders, with a positive predictive value of 93.3%. Summed VGRS scores of ≤2 had a negative 
predictive value of 73.3%. 
10. 
Mandyso
va [30] 
VAS/NRS, 
NRS, FPS-
R 
 Validity:  n=19 (24%) reported pain using at least one scale.
 Spearman correlation was 0.997 (p<0.001) between VAS/NRS and NRS.
 Feasibility:  NRS had the highest preference ranking (ranking first or second in 75% cases). 
11. 
Pomeroy 
[32] 
10-cm v-
VAS 
 Inter-rater reliability:ICC:0.79 for intensity, 0.75 for frequency and 0.62 for affective response.
 Wide limits of agreement and significant rater bias reported for 6/27 ratings.
 Intra-rater reliability  :ICC:0.70 for intensity, 0.77 for frequency and 0.69 for affective response.
12. 
Soares 
[33]
PACSLAC-
II 
 Validity  : PACSLAC-II differentiated 4.5-lb stimulus versus 2-lb (p=0.03) or 0lb (p=0.05).
 Reliability (internal)  :Cronbach α:0.87, 0.94, and 0.96 for weights of 0, 2, and 4.5 lb, respectively. 
Abbreviations:FPS = Faces Pain Scale; NRS/NPRS = Numerical Rating Scale; VAS = Visual Analogue Scale, LPS = Likert Pain Scale,
FPRS = Four-point rating scale, v-/m-/h-=vertical/mechanical/horizontal, visual graphic rating scale (VGRS), 
NPRS-FPS and VAS/NRS indicate combined versions of scales
DN4=neuropathic pain diagnostic questionnaire (DN4+ = neuropathic pain reported; DN4- = no neuropathic pain reported); PACSLAC-II=Pain
Assessment Scale for Seniors with Severe Dementia-II
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Table 3: Cross-tabulation of pain assessment tool and post stroke pain syndrome
VAS VAS-NRS FPS FPS-NRS NRS VRS ShoulderQ PACSLAC-
11
DN4
Shoulder/Arm
Pain
1 0 2 1 0 0 2 0 1
Experimental 2 0 0 0 0 0 0 1 0
Not specified 0 1 2 0 2 0 0 0 0
Neuropathic 0 0 0 0 0 0 0 0 0
Headache 0 0 0 0 0 0 0 0 0
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Figure 1:PRISMA Flow chart for selection of studies for systematic review
The first search was performed on 31st July 2019; to ensure the review was up to date we ran a repeat search on 08/05/2020. The PRISMA 
contains an aggregate of both searches.’
Figure 2:Traffic Light plot for risk of bias in individual studies
Figure 3:Harvest plot of psychometric evaluation of pain scale according to the 12 included studies. 
Each unit represents a differing study.
Colour coding is used to represent differing pain types. 
Position around horizontal line describes paper conclusions regarding the property of interest, where above the line indicates ‘good’, below the 
line indicates ‘poor’ and on the line indicates ‘uncertain’. Full description given in main manuscript.
Abbreviations: VAS=Visual Analogue Scale; NRS=Numerical Rating Scale; FPS=Faces Pain Scale; VRS=Visual Rating Scale; 
ShoulderQ=Shoulder pain questionnaire; PACSLAC-II=Pain Assessment Scale for Seniors with Severe Dementia-II; DN4=neuropathic pain 
diagnostic questionnaire; 
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